Issued: August 2012.
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2012. Publication and catalogue information, links to buy online and reader comments.